MMP9 and osteoporosis: To conclude, Alendronate reduced significantly MMP-9, improved significantly CVD risk factors and efficiently treated osteoporosis as evident by histological examination and BTM levels in Alendronate-treated group as compared to the untreated osteoporotic rats and the control sham-operated rats.